Dr. Emir Hadzijusufovic received The City of Vienna Fund for Innovative Interdisciplinary Cancer Research Prize in December 2019. His high impact work entitled: „Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site“, published 2017 in Leukemia, was awarded EUR 3.500,00.